ESCITALOPRAM OXALATE

ESCITALOPRAM OXALATE was reported 74217 times

ESCITALOPRAM OXALATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SPIROMETRY ABNORMAL 302 0.5050
1 MITE ALLERGY 288 0.4397
2 TOTAL LUNG CAPACITY ABNORMAL 143 0.3676
3 MYCOTIC ALLERGY 285 0.3333
4 PULMONARY VASCULITIS 171 0.3178
5 DUST ALLERGY 286 0.2915
6 CAPILLARITIS 75 0.2717
7 AMAUROSIS FUGAX 244 0.2266
8 VITAL CAPACITY DECREASED 100 0.2232
9 STEROID DEPENDENCE 181 0.2062
10 CONJUNCTIVITIS ALLERGIC 304 0.2051
11 REVERSIBLE AIRWAYS OBSTRUCTION 102 0.2008
12 GENITAL ANAESTHESIA 51 0.1896
13 CATARRH 167 0.1847
14 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 115 0.1569
15 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 53 0.1318
16 SPUTUM CULTURE POSITIVE 103 0.1268
17 PHYSICAL DECONDITIONING 300 0.1165
18 NEURITIS 161 0.1042
19 NORMOCHROMIC NORMOCYTIC ANAEMIA 300 0.0998
20 BURNS SECOND DEGREE 172 0.0979
21 BRONCHIAL SECRETION RETENTION 112 0.0879
22 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 169 0.0855
23 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 168 0.0823
24 SEROTONIN SYNDROME 1476 0.0768
25 GENITAL HYPOAESTHESIA 69 0.0676
26 RESPIRATORY SYMPTOM 177 0.0622
27 INTRUSIVE THOUGHTS 72 0.0611
28 MAJOR DEPRESSION 439 0.0600
29 RESPIRATORY DISORDER NEONATAL 90 0.0555
30 ALCOHOL POISONING 145 0.0541
31 FORCED EXPIRATORY VOLUME DECREASED 152 0.0536
32 HYPOPNOEA 186 0.0535
33 CLONUS 137 0.0500
34 URINARY TRACT DISORDER 220 0.0488
35 SUSPECTED SUICIDE 212 0.0452
36 EMOTIONAL POVERTY 79 0.0450
37 SLEEP TALKING 76 0.0447
38 HYPERREFLEXIA 154 0.0442
39 SMALL FOR DATES BABY 219 0.0441
40 SLEEP TERROR 185 0.0439
41 HAEMORRHAGIC STROKE 334 0.0427
42 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 210 0.0409
43 FULL BLOOD COUNT ABNORMAL 433 0.0409
44 ELECTRIC SHOCK SENSATION 114 0.0407
45 ANORGASMIA 110 0.0405
46 LONG QT SYNDROME 96 0.0400
47 BLOOD PRESSURE DIASTOLIC ABNORMAL 101 0.0397
48 PSYCHOMOTOR RETARDATION 109 0.0387
49 DEPRESSIVE SYMPTOM 135 0.0383
50 ARTERIOSCLEROSIS CORONARY ARTERY 252 0.0380
51 MULTIPLE DRUG OVERDOSE INTENTIONAL 117 0.0363
52 SEXUAL DYSFUNCTION 394 0.0336
53 SOPOR 444 0.0335
54 NEUROLOGICAL SYMPTOM 188 0.0329
55 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 337 0.0328
56 DEREALISATION 70 0.0325
57 TORSADE DE POINTES 254 0.0323
58 BLOOD PRESSURE SYSTOLIC ABNORMAL 80 0.0323
59 ANTICHOLINERGIC SYNDROME 51 0.0320
60 PULMONARY ALVEOLAR HAEMORRHAGE 178 0.0317
61 TORTICOLLIS 66 0.0311
62 SUICIDE ATTEMPT 1857 0.0306
63 ELECTROCARDIOGRAM QT PROLONGED 1101 0.0306
64 ARTERIOSCLEROSIS 283 0.0300
65 BRONCHIECTASIS 202 0.0300
66 HYPOMANIA 109 0.0296
67 TALIPES 92 0.0296
68 OBSTRUCTIVE AIRWAYS DISORDER 329 0.0295
69 LOSS OF LIBIDO 265 0.0294
70 PERSECUTORY DELUSION 70 0.0280
71 POISONING DELIBERATE 266 0.0280
72 HYPERPARATHYROIDISM SECONDARY 70 0.0279
73 COLITIS MICROSCOPIC 132 0.0278
74 INTENTIONAL OVERDOSE 1781 0.0277
75 OCULAR DISCOMFORT 298 0.0265
76 PAROSMIA 199 0.0263
77 LIBIDO INCREASED 53 0.0261
78 RHINITIS 210 0.0260
79 NEPHROGENIC ANAEMIA 120 0.0259
80 SEDATION COMPLICATION 66 0.0258
81 GINGIVAL PAIN 205 0.0257
82 NODULE 333 0.0255
83 BRADYKINESIA 150 0.0254
84 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 430 0.0253
85 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 67 0.0252
86 COMPLETED SUICIDE 2086 0.0250
87 REBOUND ACID HYPERSECRETION 75 0.0248
88 YAWNING 66 0.0247
89 HYPERTONIA 140 0.0244
90 CEREBRAL HAEMATOMA 81 0.0241
91 INTENTIONAL SELF-INJURY 484 0.0239
92 MUSCLE RIGIDITY 285 0.0238
93 CARDIAC MURMUR 202 0.0233
94 GENERALISED OEDEMA 288 0.0232
95 ANXIETY DISORDER 77 0.0230
96 TEMPERATURE REGULATION DISORDER 51 0.0229
97 IMPAIRED QUALITY OF LIFE 324 0.0225
98 MYDRIASIS 289 0.0225
99 COMA SCALE ABNORMAL 65 0.0224
100 ATRIAL SEPTAL DEFECT 179 0.0214
101 AKATHISIA 291 0.0213
102 ALTERED STATE OF CONSCIOUSNESS 458 0.0211
103 CATATONIA 111 0.0211
104 POTENTIATING DRUG INTERACTION 69 0.0205
105 HEAD DISCOMFORT 362 0.0204
106 FEELING OF DESPAIR 95 0.0204
107 MULTIPLE ALLERGIES 156 0.0199
108 NEUROLEPTIC MALIGNANT SYNDROME 236 0.0199
109 DRUG INTERACTION 3151 0.0198
110 MANIA 326 0.0198
111 BUNDLE BRANCH BLOCK LEFT 84 0.0198
112 MYOCLONUS 234 0.0196
113 BRUXISM 105 0.0195
114 BEHAVIOUR DISORDER 105 0.0194
115 HYPERTHERMIA 147 0.0192
116 BRADYPHRENIA 125 0.0191
117 POLYDIPSIA 75 0.0190
118 COMA 893 0.0187
119 STUPOR 60 0.0187
120 SWOLLEN TONGUE 578 0.0185
121 PARKINSONISM 180 0.0184
122 HYPONATRAEMIA 1038 0.0184
123 IMPULSIVE BEHAVIOUR 69 0.0184
124 VASCULITIS 212 0.0182
125 UPPER-AIRWAY COUGH SYNDROME 149 0.0181
126 SUICIDAL IDEATION 1638 0.0179
127 GESTATIONAL DIABETES 85 0.0178
128 DELUSION 274 0.0176
129 SINUS BRADYCARDIA 170 0.0176
130 EXPOSURE VIA BREAST MILK 70 0.0176
131 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 844 0.0176
132 HALLUCINATIONS, MIXED 73 0.0173
133 RED CELL DISTRIBUTION WIDTH INCREASED 72 0.0173
134 CYTOLYTIC HEPATITIS 57 0.0172
135 AUTONOMIC NERVOUS SYSTEM IMBALANCE 50 0.0171
136 METABOLIC ACIDOSIS 543 0.0170
137 SUICIDAL BEHAVIOUR 70 0.0168
138 HAEMATEMESIS 424 0.0167
139 AFFECTIVE DISORDER 131 0.0166
140 APATHY 243 0.0166
141 VENTRICULAR SEPTAL DEFECT 95 0.0166
142 SINUS TACHYCARDIA 232 0.0163
143 SELF-INJURIOUS IDEATION 68 0.0162
144 TACHYPHRENIA 56 0.0162
145 ORTHOSTATIC HYPOTENSION 279 0.0160
146 PRESYNCOPE 388 0.0159
147 MULTIPLE DRUG OVERDOSE 79 0.0159
148 PHOTOPHOBIA 299 0.0159
149 CARDIO-RESPIRATORY ARREST 663 0.0158
150 PANIC DISORDER 61 0.0157
151 ALCOHOLISM 67 0.0156
152 HALLUCINATION, VISUAL 327 0.0155
153 HALLUCINATION, AUDITORY 245 0.0154
154 EOSINOPHIL COUNT INCREASED 128 0.0153
155 CARDIOGENIC SHOCK 220 0.0153
156 TINNITUS 704 0.0153
157 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 93 0.0153
158 BUNDLE BRANCH BLOCK RIGHT 70 0.0152
159 HYPERACUSIS 56 0.0150
160 HYPOMAGNESAEMIA 205 0.0147
161 TUBULOINTERSTITIAL NEPHRITIS 275 0.0147
162 GALACTORRHOEA 94 0.0146
163 IRON DEFICIENCY 65 0.0144
164 HAEMODYNAMIC INSTABILITY 110 0.0144
165 TONSILLITIS 75 0.0144
166 IMPAIRED WORK ABILITY 307 0.0143
167 FREEZING PHENOMENON 53 0.0143
168 TENSION 87 0.0143
169 LOGORRHOEA 50 0.0142
170 TRISMUS 73 0.0141
171 SEDATION 368 0.0140
172 HYPOTONIA 140 0.0140
173 SNORING 53 0.0140
174 MATERNAL DRUGS AFFECTING FOETUS 107 0.0139
175 ON AND OFF PHENOMENON 77 0.0139
176 DIPLOPIA 360 0.0138
177 HYPERNATRAEMIA 69 0.0138
178 HOMICIDAL IDEATION 56 0.0138
179 NIGHTMARE 478 0.0138
180 RESTLESSNESS 504 0.0138
181 PANIC ATTACK 501 0.0137
182 MUSCLE TWITCHING 315 0.0137
183 NASAL POLYPS 67 0.0136
184 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 120 0.0136
185 AGITATION 987 0.0134
186 PULSELESS ELECTRICAL ACTIVITY 56 0.0134
187 ANAL INCONTINENCE 120 0.0133
188 HYPERPHAGIA 53 0.0133
189 HYPOXIA 468 0.0133
190 PARANOIA 229 0.0133
191 TACHYCARDIA 1170 0.0132
192 WITHDRAWAL SYNDROME 549 0.0131
193 TOXIC ENCEPHALOPATHY 66 0.0130
194 PSYCHIATRIC SYMPTOM 96 0.0130
195 POISONING 163 0.0130
196 ERECTILE DYSFUNCTION 333 0.0130
197 FOETAL EXPOSURE DURING PREGNANCY 1053 0.0129
198 ELECTROCARDIOGRAM ABNORMAL 101 0.0129
199 POST-TRAUMATIC STRESS DISORDER 86 0.0128
200 FAECALOMA 70 0.0128
201 IMPAIRED GASTRIC EMPTYING 174 0.0128
202 DECREASED INTEREST 75 0.0127
203 SOMNOLENCE 2536 0.0126
204 DEPRESSED LEVEL OF CONSCIOUSNESS 494 0.0125
205 PANIC REACTION 90 0.0125
206 NYSTAGMUS 66 0.0124
207 DEPRESSED MOOD 653 0.0123
208 FOETAL GROWTH RESTRICTION 75 0.0123
209 MIOSIS 99 0.0123
210 ANHEDONIA 321 0.0122
211 SOMNAMBULISM 80 0.0122
212 PRODUCTIVE COUGH 579 0.0121
213 PRODUCT SUBSTITUTION ISSUE 689 0.0120
214 DYSKINESIA 485 0.0119
215 COGNITIVE DISORDER 555 0.0119
216 FREQUENT BOWEL MOVEMENTS 321 0.0119
217 SKIN ABRASION 56 0.0118
218 GENERALISED TONIC-CLONIC SEIZURE 196 0.0118
219 PSYCHOMOTOR HYPERACTIVITY 196 0.0118
220 ASCITES 347 0.0118
221 DEPRESSION 2672 0.0117
222 PRODUCT ADMINISTRATION INTERRUPTED 92 0.0117
223 BLOOD PROLACTIN INCREASED 55 0.0117
224 OBSESSIVE-COMPULSIVE DISORDER 93 0.0116
225 TOXICITY TO VARIOUS AGENTS 1948 0.0115
226 BLOOD PRESSURE SYSTOLIC INCREASED 225 0.0115
227 RESTLESS LEGS SYNDROME 209 0.0115
228 RESPIRATORY TRACT INFECTION 299 0.0115
229 PULMONARY FIBROSIS 220 0.0115
230 HYPOKINESIA 166 0.0114
231 DRUG WITHDRAWAL SYNDROME NEONATAL 169 0.0114
232 DISTURBANCE IN ATTENTION 611 0.0113
233 DELIRIUM 389 0.0112
234 OVERWEIGHT 60 0.0112
235 BRAIN INJURY 111 0.0111
236 SLEEP DISORDER 778 0.0110
237 INITIAL INSOMNIA 113 0.0110
238 END STAGE RENAL DISEASE 200 0.0110
239 MENTAL DISORDER 477 0.0109
240 DRUG LEVEL INCREASED 181 0.0109
241 VENTRICULAR FIBRILLATION 121 0.0109
242 HALLUCINATION 820 0.0109
243 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 769 0.0108
244 ANXIETY 3058 0.0107
245 SOCIAL AVOIDANT BEHAVIOUR 62 0.0107
246 CONFUSIONAL STATE 1731 0.0107
247 HYPOKALAEMIA 494 0.0107
248 TROPONIN INCREASED 81 0.0106
249 TREMOR 1748 0.0105
250 WHEEZING 624 0.0105
251 SALIVARY HYPERSECRETION 105 0.0105
252 NORMAL NEWBORN 57 0.0105
253 POOR QUALITY SLEEP 224 0.0104
254 VITAMIN D DEFICIENCY 100 0.0102
255 HAEMATURIA 347 0.0101
256 PSYCHOTIC DISORDER 299 0.0101
257 BRAIN FOG 158 0.0101
258 EYE PAIN 568 0.0101
259 CHRONIC KIDNEY DISEASE 762 0.0100
260 URINARY INCONTINENCE 297 0.0100
261 HAEMOPTYSIS 279 0.0100
262 RHABDOMYOLYSIS 417 0.0100
263 ACUTE KIDNEY INJURY 1522 0.0099
264 BRADYCARDIA 527 0.0099
265 PULMONARY MASS 147 0.0099
266 DYSGRAPHIA 65 0.0099
267 MYOPATHY 85 0.0098
268 CONCUSSION 76 0.0098
269 GAMMA-GLUTAMYLTRANSFERASE INCREASED 217 0.0098
270 COORDINATION ABNORMAL 136 0.0097
271 RIB FRACTURE 200 0.0097
272 VERTIGO 591 0.0097
273 ACCIDENTAL OVERDOSE 353 0.0096
274 POLYURIA 79 0.0096
275 CRYING 349 0.0096
276 HAEMATOMA 248 0.0096
277 HYPOVOLAEMIA 56 0.0096
278 ATRIOVENTRICULAR BLOCK COMPLETE 64 0.0096
279 SEASONAL ALLERGY 135 0.0095
280 ANGIOEDEMA 420 0.0095
281 BIPOLAR DISORDER 103 0.0095
282 HEPATITIS CHOLESTATIC 57 0.0095
283 THINKING ABNORMAL 176 0.0094
284 FALL 3140 0.0094
285 DISORIENTATION 373 0.0094
286 DRUG ABUSE 783 0.0094
287 HYPOTHYROIDISM 299 0.0094
288 BLINDNESS 379 0.0093
289 PRE-EXISTING CONDITION IMPROVED 58 0.0093
290 DECREASED ACTIVITY 100 0.0093
291 BODY TEMPERATURE DECREASED 91 0.0092
292 HEPATIC STEATOSIS 172 0.0092
293 CONDITION AGGRAVATED 2805 0.0092
294 URINARY RETENTION 307 0.0092
295 ECCHYMOSIS 63 0.0092
296 DIZZINESS POSTURAL 89 0.0092
297 HYPERSOMNIA 263 0.0092
298 MENTAL IMPAIRMENT 222 0.0091
299 PULMONARY EMBOLISM 866 0.0091
300 WALKING AID USER 60 0.0091
301 ATRIOVENTRICULAR BLOCK 70 0.0090
302 UNRESPONSIVE TO STIMULI 233 0.0090
303 SYNCOPE 901 0.0090
304 FORMICATION 62 0.0089
305 LIGAMENT SPRAIN 88 0.0089
306 WEIGHT FLUCTUATION 93 0.0089
307 MEDICATION ERROR 493 0.0089
308 STATUS EPILEPTICUS 100 0.0088
309 AGGRESSION 443 0.0088
310 CHOLESTASIS 169 0.0088
311 HYPERPROLACTINAEMIA 57 0.0088
312 MUSCLE SPASTICITY 108 0.0088
313 HEAD INJURY 278 0.0088
314 BALANCE DISORDER 757 0.0087
315 BLOOD PRESSURE FLUCTUATION 209 0.0087
316 RECTAL HAEMORRHAGE 373 0.0087
317 BODY TEMPERATURE INCREASED 177 0.0087
318 OXYGEN SATURATION DECREASED 487 0.0087
319 APHTHOUS ULCER 67 0.0086
320 DYSPHONIA 505 0.0086
321 RESPIRATORY ARREST 238 0.0086
322 EYE MOVEMENT DISORDER 59 0.0086
323 HYPOCALCAEMIA 163 0.0086
324 RESPIRATORY DEPRESSION 105 0.0086
325 GRAND MAL CONVULSION 79 0.0085
326 FEELING JITTERY 163 0.0085
327 CEREBRAL DISORDER 63 0.0085
328 ATAXIA 101 0.0085
329 LIPASE INCREASED 65 0.0085
330 HEPATOCELLULAR INJURY 120 0.0085
331 MYOCARDITIS 97 0.0085
332 SUBDURAL HAEMATOMA 121 0.0084
333 HAEMATOCHEZIA 465 0.0084
334 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 215 0.0083
335 MIDDLE INSOMNIA 156 0.0083
336 BLOOD IRON DECREASED 99 0.0083
337 IRRITABILITY 501 0.0083
338 EUPHORIC MOOD 85 0.0083
339 APPETITE DISORDER 55 0.0083
340 DERMATITIS ALLERGIC 104 0.0083
341 INFUSION SITE SWELLING 52 0.0083
342 EPILEPSY 252 0.0082
343 HYPERHIDROSIS 1062 0.0082
344 DEMENTIA 229 0.0082
345 COELIAC DISEASE 80 0.0081
346 INCONTINENCE 86 0.0081
347 BLEPHAROSPASM 51 0.0081
348 SKIN LACERATION 88 0.0081
349 APNOEA 63 0.0081
350 LYMPHOCYTE COUNT DECREASED 143 0.0081
351 EXTRASYSTOLES 56 0.0080
352 SLEEP APNOEA SYNDROME 153 0.0080
353 INSOMNIA 2135 0.0080
354 EXTRAPYRAMIDAL DISORDER 198 0.0080
355 DISSOCIATION 61 0.0079
356 COLITIS ULCERATIVE 355 0.0079
357 POOR VENOUS ACCESS 82 0.0079
358 HEPATIC CYTOLYSIS 101 0.0079
359 HYPERAESTHESIA 65 0.0079
360 CAESAREAN SECTION 92 0.0079
361 INTERVERTEBRAL DISC DEGENERATION 73 0.0079
362 CARDIAC ARREST 649 0.0079
363 ENCEPHALOPATHY 193 0.0079
364 BLOOD COUNT ABNORMAL 119 0.0078
365 DYSTONIA 152 0.0078
366 ARTHROPOD BITE 58 0.0078
367 SENSORY LOSS 63 0.0078
368 BLOOD ALBUMIN DECREASED 62 0.0078
369 SPUTUM DISCOLOURED 74 0.0078
370 POLYP 51 0.0078
371 APHASIA 235 0.0078
372 INCREASED APPETITE 148 0.0077
373 DRUG USE DISORDER 65 0.0077
374 THERAPY CHANGE 76 0.0077
375 INCOHERENT 50 0.0077
376 ASPHYXIA 63 0.0077
377 HYPOTENSION 1544 0.0077
378 JOINT EFFUSION 53 0.0077
379 ECZEMA 401 0.0077
380 ABNORMAL DREAMS 211 0.0076
381 DYSARTHRIA 287 0.0076
382 SEIZURE 879 0.0076
383 UPPER GASTROINTESTINAL HAEMORRHAGE 128 0.0076
384 VENTRICULAR EXTRASYSTOLES 79 0.0076
385 NERVE COMPRESSION 70 0.0076
386 ELECTROLYTE IMBALANCE 88 0.0076
387 BLOOD CREATINE PHOSPHOKINASE INCREASED 218 0.0076
388 MOTOR DYSFUNCTION 77 0.0075
389 HEART RATE DECREASED 265 0.0075
390 CLOSTRIDIUM DIFFICILE COLITIS 80 0.0075
391 BEDRIDDEN 99 0.0075
392 NEUTROPHIL COUNT INCREASED 77 0.0075
393 SWELLING FACE 489 0.0075
394 PALPITATIONS 878 0.0075
395 THERAPY NON-RESPONDER 336 0.0075
396 INFUSION SITE ERYTHEMA 63 0.0075
397 ABNORMAL BEHAVIOUR 296 0.0075
398 ANGER 252 0.0074
399 RESPIRATORY RATE INCREASED 66 0.0074
400 WRIST FRACTURE 89 0.0074
401 ASTHMA 839 0.0074
402 LETHARGY 427 0.0074
403 INTENTIONAL PRODUCT USE ISSUE 650 0.0074
404 LIVE BIRTH 62 0.0074
405 VENTRICULAR TACHYCARDIA 122 0.0074
406 DEEP VEIN THROMBOSIS 479 0.0074
407 SUBSTANCE ABUSE 60 0.0074
408 SPINAL OSTEOARTHRITIS 64 0.0073
409 LUNG DISORDER 356 0.0073
410 MENTAL STATUS CHANGES 201 0.0072
411 PRODUCT PRESCRIBING ERROR 172 0.0072
412 SHOCK 165 0.0072
413 ACUTE RESPIRATORY FAILURE 138 0.0072
414 PEMPHIGOID 54 0.0071
415 QUALITY OF LIFE DECREASED 96 0.0071
416 IRON DEFICIENCY ANAEMIA 66 0.0071
417 MIGRAINE 682 0.0071
418 PREMATURE BABY 215 0.0071
419 PRESCRIBED OVERDOSE 138 0.0071
420 LOSS OF CONSCIOUSNESS 912 0.0071
421 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 122 0.0071
422 ISCHAEMIC STROKE 127 0.0071
423 DRUG INTOLERANCE 686 0.0071
424 HOSPICE CARE 70 0.0071
425 BLOOD POTASSIUM DECREASED 213 0.0071
426 TOOTH FRACTURE 78 0.0071
427 BLOOD PRESSURE INCREASED 1080 0.0071
428 THROMBOSIS 568 0.0071
429 FRUSTRATION TOLERANCE DECREASED 57 0.0070
430 AGRANULOCYTOSIS 131 0.0070
431 BLOOD PRESSURE DIASTOLIC DECREASED 52 0.0070
432 EAR DISCOMFORT 72 0.0070
433 BLOOD SODIUM DECREASED 132 0.0070
434 FOOD ALLERGY 54 0.0070
435 INFUSION SITE PAIN 90 0.0070
436 BLADDER DISORDER 69 0.0069
437 BLOOD CALCIUM DECREASED 78 0.0069
438 MICTURITION URGENCY 79 0.0069
439 MITRAL VALVE INCOMPETENCE 78 0.0069
440 TREATMENT NONCOMPLIANCE 377 0.0069
441 NIGHT SWEATS 222 0.0069
442 BLOOD ALKALINE PHOSPHATASE INCREASED 171 0.0069
443 COVID-19 1205 0.0069
444 ANURIA 59 0.0068
445 PHARYNGEAL SWELLING 67 0.0068
446 PNEUMONIA ASPIRATION 171 0.0068
447 OSTEOARTHRITIS 290 0.0068
448 PSYCHOLOGICAL TRAUMA 59 0.0068
449 MOOD ALTERED 186 0.0068
450 HIATUS HERNIA 88 0.0068
451 PREGNANCY 136 0.0068
452 C-REACTIVE PROTEIN INCREASED 247 0.0068
453 HYPOGLYCAEMIA 329 0.0068
454 RED BLOOD CELL SEDIMENTATION RATE INCREASED 75 0.0068
455 HAEMATOCRIT DECREASED 134 0.0068
456 ARRHYTHMIA 320 0.0068
457 AFFECT LABILITY 65 0.0067
458 DECUBITUS ULCER 55 0.0067
459 GAIT INABILITY 225 0.0067
460 MUSCLE TIGHTNESS 109 0.0067
461 NECK PAIN 376 0.0067
462 FACIAL PAIN 60 0.0067
463 DECREASED APPETITE 1560 0.0067
464 DRUG SCREEN POSITIVE 53 0.0067
465 SPEECH DISORDER 351 0.0067
466 CIRCULATORY COLLAPSE 114 0.0067
467 AMNESIA 434 0.0067
468 HEAVY MENSTRUAL BLEEDING 60 0.0067
469 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 365 0.0066
470 MUSCULOSKELETAL STIFFNESS 580 0.0066
471 EMOTIONAL DISORDER 204 0.0066
472 FLANK PAIN 62 0.0066
473 DRUG TOXICITY 90 0.0066
474 MOVEMENT DISORDER 212 0.0066
475 MEMORY IMPAIRMENT 906 0.0066
476 ABNORMAL FAECES 54 0.0066
477 CHILLS 771 0.0066
478 PERSONALITY CHANGE 61 0.0066
479 VITAMIN D DECREASED 56 0.0065
480 DEHYDRATION 873 0.0065
481 PRODUCT ADMINISTRATION ERROR 132 0.0065
482 ATELECTASIS 63 0.0065
483 DYSPNOEA EXERTIONAL 245 0.0065
484 INTERVERTEBRAL DISC PROTRUSION 142 0.0065
485 SUBARACHNOID HAEMORRHAGE 66 0.0065
486 URINARY TRACT INFECTION 1105 0.0065
487 ARTHRITIS 508 0.0065
488 WEIGHT INCREASED 1444 0.0064
489 FEAR 173 0.0064
490 TRICUSPID VALVE INCOMPETENCE 51 0.0064
491 GASTRIC ULCER 122 0.0064
492 ABDOMINAL PAIN 1492 0.0064
493 SKIN HAEMORRHAGE 95 0.0064
494 LIVER FUNCTION TEST INCREASED 137 0.0064
495 THIRST 114 0.0064
496 DIZZINESS 3179 0.0064
497 SYSTEMIC LUPUS ERYTHEMATOSUS 226 0.0064
498 GRIP STRENGTH DECREASED 56 0.0064
499 GENERAL PHYSICAL HEALTH DETERIORATION 734 0.0063
500 POLLAKIURIA 263 0.0063
501 ASPIRATION 69 0.0063
502 PRODUCT DOSE OMISSION IN ERROR 178 0.0063
503 CEREBRAL HAEMORRHAGE 225 0.0063
504 ASTHENIA 2350 0.0062
505 RETCHING 133 0.0062
506 PYELONEPHRITIS 54 0.0062
507 OVERDOSE 1342 0.0062
508 PRODUCT USE IN UNAPPROVED INDICATION 1537 0.0062
509 GASTROINTESTINAL PAIN 68 0.0062
510 TRANSAMINASES INCREASED 137 0.0062
511 HYPERKALAEMIA 216 0.0062
512 RED BLOOD CELL COUNT DECREASED 176 0.0061
513 WEIGHT DECREASED 1717 0.0061
514 PRODUCT DISTRIBUTION ISSUE 57 0.0061
515 HEADACHE 3852 0.0061
516 SUDDEN DEATH 65 0.0061
517 ECONOMIC PROBLEM 93 0.0061
518 ALANINE AMINOTRANSFERASE INCREASED 376 0.0061
519 ABDOMINAL DISCOMFORT 1025 0.0061
520 THERAPY PARTIAL RESPONDER 95 0.0061
521 ANKYLOSING SPONDYLITIS 80 0.0061
522 FATIGUE 4721 0.0061
523 MOOD SWINGS 193 0.0060
524 NERVOUSNESS 316 0.0060
525 GASTROOESOPHAGEAL REFLUX DISEASE 486 0.0060
526 INTERNATIONAL NORMALISED RATIO INCREASED 172 0.0060
527 DRY MOUTH 489 0.0060
528 OBESITY 96 0.0060
529 INSURANCE ISSUE 92 0.0060
530 MUSCULOSKELETAL CHEST PAIN 93 0.0060
531 TEMPERATURE INTOLERANCE 62 0.0060
532 FEELING COLD 167 0.0060
533 TOXIC EPIDERMAL NECROLYSIS 91 0.0060
534 BLOOD POTASSIUM INCREASED 97 0.0060
535 BRONCHITIS 441 0.0060
536 VOMITING 2801 0.0060
537 DISCOMFORT 363 0.0059
538 DIARRHOEA 3828 0.0059
539 DYSSTASIA 173 0.0059
540 DYSURIA 218 0.0059
541 CYSTITIS 188 0.0059
542 INTENTIONAL DOSE OMISSION 168 0.0059
543 SPINAL PAIN 69 0.0059
544 HOT FLUSH 443 0.0059
545 PURPURA 52 0.0059
546 INCREASED TENDENCY TO BRUISE 54 0.0059
547 COUGH 1645 0.0059
548 LEUKOCYTOSIS 106 0.0059
549 LIMB INJURY 159 0.0058
550 ADRENAL INSUFFICIENCY 71 0.0058
551 GAIT DISTURBANCE 1118 0.0058
552 ABSCESS 93 0.0058
553 HYPOTHERMIA 59 0.0058
554 FEEDING DISORDER 118 0.0058
555 HUNGER 81 0.0058
556 BREAST PAIN 62 0.0058
557 MYALGIA 987 0.0058
558 DRUG LEVEL DECREASED 59 0.0058
559 SKIN INFECTION 65 0.0058
560 SLUGGISHNESS 59 0.0058
561 HEART RATE INCREASED 570 0.0057
562 AUTOIMMUNE DISORDER 56 0.0057
563 ORAL HERPES 112 0.0057
564 TACHYPNOEA 78 0.0057
565 RENAL INJURY 170 0.0057
566 MALNUTRITION 64 0.0057
567 SEPSIS 638 0.0057
568 DISEASE RECURRENCE 272 0.0057
569 CARDIOTOXICITY 51 0.0057
570 RENAL TUBULAR NECROSIS 56 0.0057
571 DYSGEUSIA 424 0.0057
572 DIVERTICULITIS 158 0.0057
573 HIP FRACTURE 183 0.0057
574 SMALL INTESTINAL OBSTRUCTION 70 0.0057
575 NOCTURIA 69 0.0057
576 PLATELET COUNT INCREASED 74 0.0057
577 GASTROINTESTINAL DISORDER 508 0.0057
578 SECRETION DISCHARGE 71 0.0057
579 OSTEOPENIA 86 0.0057
580 VISION BLURRED 778 0.0057
581 TOXIC SKIN ERUPTION 57 0.0057
582 EOSINOPHILIA 99 0.0056
583 SUPRAVENTRICULAR TACHYCARDIA 54 0.0056
584 CONSTIPATION 1230 0.0056
585 NAUSEA 4462 0.0056
586 NEURALGIA 137 0.0056
587 PRESCRIBED UNDERDOSE 112 0.0056
588 HYPOPHAGIA 143 0.0056
589 TOOTHACHE 101 0.0056
590 MUSCULAR WEAKNESS 633 0.0056
591 CARPAL TUNNEL SYNDROME 78 0.0056
592 TENDERNESS 58 0.0056
593 LACTIC ACIDOSIS 180 0.0056
594 SENSORY DISTURBANCE 89 0.0055
595 GLOMERULAR FILTRATION RATE DECREASED 68 0.0055
596 MOUTH ULCERATION 116 0.0055
597 DECREASED IMMUNE RESPONSIVENESS 54 0.0055
598 CLOSTRIDIUM DIFFICILE INFECTION 120 0.0055
599 CONTUSION 528 0.0055
600 PHARYNGITIS 68 0.0055
601 PANCREATITIS ACUTE 123 0.0055
602 UPPER LIMB FRACTURE 109 0.0055
603 FIBROMYALGIA 133 0.0055
604 MOBILITY DECREASED 393 0.0055
605 SCIATICA 87 0.0055
606 ABDOMINAL PAIN UPPER 1123 0.0054
607 CANDIDA INFECTION 92 0.0054
608 PRODUCT AVAILABILITY ISSUE 124 0.0054
609 BLOOD THYROID STIMULATING HORMONE INCREASED 50 0.0054
610 MELAENA 119 0.0054
611 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 974 0.0054
612 HYPERTENSIVE CRISIS 60 0.0054
613 LYMPHOPENIA 76 0.0054
614 BLOOD BILIRUBIN INCREASED 145 0.0054
615 FEELING HOT 329 0.0054
616 MUSCULOSKELETAL DISCOMFORT 92 0.0053
617 PARAESTHESIA 840 0.0053
618 INFLUENZA 595 0.0053
619 MALAISE 2339 0.0053
620 GOUT 95 0.0053
621 ADVERSE DRUG REACTION 475 0.0053
622 BLOOD PRESSURE DECREASED 351 0.0053
623 DYSPNOEA 2988 0.0053
624 HERNIA 102 0.0053
625 ASPARTATE AMINOTRANSFERASE INCREASED 280 0.0053
626 THERAPY CESSATION 270 0.0053
627 FEELING ABNORMAL 1260 0.0053
628 KIDNEY INFECTION 103 0.0052
629 OROPHARYNGEAL PAIN 484 0.0052
630 BRAIN OEDEMA 66 0.0052
631 NASAL CONGESTION 307 0.0052
632 RESPIRATORY DISTRESS 144 0.0052
633 SCRATCH 55 0.0052
634 ILLNESS 537 0.0052
635 SPLENOMEGALY 61 0.0052
636 PAIN IN EXTREMITY 1533 0.0052
637 EYE DISCHARGE 54 0.0052
638 DERMATITIS ATOPIC 274 0.0052
639 BURSITIS 63 0.0052
640 LIMB DISCOMFORT 160 0.0052
641 RENAL FAILURE 686 0.0052
642 WHITE BLOOD CELL COUNT INCREASED 198 0.0052
643 TOOTH INFECTION 68 0.0052
644 DYSPHAGIA 489 0.0051
645 NASOPHARYNGITIS 943 0.0051
646 FACE OEDEMA 86 0.0051
647 SCAB 58 0.0051
648 FOOT FRACTURE 96 0.0051
649 NERVOUS SYSTEM DISORDER 158 0.0051
650 THERAPY INTERRUPTED 361 0.0050
651 HYPERTENSION 1070 0.0050
652 SINUS DISORDER 100 0.0050
653 PULMONARY THROMBOSIS 55 0.0050
654 EATING DISORDER 107 0.0050
655 PREMATURE DELIVERY 80 0.0050
656 CHOKING 98 0.0050
657 HYPERBILIRUBINAEMIA 52 0.0050
658 SCHIZOPHRENIA 61 0.0050
659 ATRIAL FIBRILLATION 487 0.0050
660 TARDIVE DYSKINESIA 141 0.0050
661 SARS-COV-2 TEST POSITIVE 66 0.0050
662 PYREXIA 1727 0.0050
663 PNEUMONIA 1615 0.0050
664 BLOOD PRESSURE ABNORMAL 99 0.0050
665 PRODUCT DOSE OMISSION 325 0.0050
666 HYPOAESTHESIA 743 0.0050
667 HERPES ZOSTER 285 0.0050
668 PERIPHERAL SWELLING 760 0.0049
669 RHINORRHOEA 318 0.0049
670 JOINT INJURY 105 0.0049
671 THERAPEUTIC PRODUCT EFFECT DECREASED 220 0.0049
672 GINGIVAL BLEEDING 67 0.0049
673 MULTIPLE SCLEROSIS RELAPSE 335 0.0049
674 PALLOR 133 0.0049
675 COLD SWEAT 86 0.0049
676 CENTRAL NERVOUS SYSTEM LESION 67 0.0049
677 ARTHRALGIA 2025 0.0049
678 GASTRITIS 128 0.0049
679 INJECTION SITE EXTRAVASATION 60 0.0049
680 DRUG ERUPTION 86 0.0048
681 DRUG-INDUCED LIVER INJURY 152 0.0048
682 PHOTOSENSITIVITY REACTION 80 0.0048
683 MYOCARDIAL ISCHAEMIA 55 0.0048
684 DEVICE OCCLUSION 68 0.0048
685 UPPER RESPIRATORY TRACT INFECTION 223 0.0048
686 SINUS CONGESTION 65 0.0048
687 DYSPEPSIA 473 0.0048
688 IRRITABLE BOWEL SYNDROME 103 0.0048
689 FISTULA 54 0.0048
690 MULTIPLE SCLEROSIS 229 0.0048
691 ANAEMIA 912 0.0048
692 THERAPEUTIC RESPONSE SHORTENED 158 0.0048
693 DEVICE DISLOCATION 207 0.0048
694 PSORIATIC ARTHROPATHY 193 0.0048
695 BLOOD URINE PRESENT 90 0.0047
696 SINUSITIS 485 0.0047
697 WOUND 132 0.0047
698 BLOOD UREA INCREASED 79 0.0047
699 ANKLE FRACTURE 73 0.0047
700 FULL BLOOD COUNT DECREASED 95 0.0047
701 ACCIDENT 56 0.0047
702 CHEST DISCOMFORT 480 0.0047
703 HAEMORRHAGE INTRACRANIAL 70 0.0047
704 NERVE INJURY 52 0.0047
705 HAEMOGLOBIN DECREASED 480 0.0047
706 GLAUCOMA 90 0.0047
707 NEPHROLITHIASIS 214 0.0047
708 PAIN IN JAW 132 0.0047
709 MATERNAL EXPOSURE DURING PREGNANCY 415 0.0047
710 OEDEMA PERIPHERAL 562 0.0046
711 EXPOSURE DURING PREGNANCY 286 0.0046
712 PULMONARY OEDEMA 206 0.0046
713 VIRAL INFECTION 153 0.0046
714 GASTROENTERITIS VIRAL 83 0.0046
715 OFF LABEL USE 4018 0.0046
716 PRODUCT DOSE OMISSION ISSUE 1342 0.0046
717 TREATMENT FAILURE 378 0.0046
718 HYPERSENSITIVITY 841 0.0045
719 EAR INFECTION 120 0.0045
720 RASH ERYTHEMATOUS 215 0.0045
721 SKIN DISORDER 150 0.0045
722 COVID-19 PNEUMONIA 53 0.0045
723 HEMIPARESIS 76 0.0045
724 LIVER INJURY 110 0.0045
725 DERMATITIS CONTACT 51 0.0045
726 HEPATIC CIRRHOSIS 84 0.0045
727 VISUAL IMPAIRMENT 552 0.0044
728 RASH PRURITIC 241 0.0044
729 PERIPHERAL COLDNESS 61 0.0044
730 EAR PAIN 86 0.0044
731 JAUNDICE 119 0.0044
732 MUSCLE ATROPHY 56 0.0044
733 PANCYTOPENIA 247 0.0044
734 MULTIPLE ORGAN DYSFUNCTION SYNDROME 125 0.0044
735 BLOOD CREATININE INCREASED 288 0.0044
736 HAEMORRHOIDS 86 0.0044
737 PRURITUS 1694 0.0044
738 RESPIRATORY TRACT CONGESTION 70 0.0044
739 ORAL CANDIDIASIS 58 0.0044
740 FLUSHING 446 0.0044
741 RESPIRATORY DISORDER 131 0.0044
742 LEUKOPENIA 219 0.0044
743 OSTEOPOROSIS 180 0.0044
744 SKIN LESION 120 0.0044
745 HYPERCALCAEMIA 54 0.0044
746 PROTEINURIA 83 0.0044
747 COLITIS 165 0.0043
748 FUNGAL INFECTION 145 0.0043
749 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 227 0.0043
750 SKIN FISSURES 85 0.0043
751 DRY EYE 217 0.0043
752 TASTE DISORDER 88 0.0043
753 RESPIRATORY FAILURE 316 0.0043
754 CHOLELITHIASIS 142 0.0043
755 CYANOSIS 68 0.0043
756 ACUTE RESPIRATORY DISTRESS SYNDROME 76 0.0043
757 HEART RATE IRREGULAR 97 0.0043
758 HYPERTHYROIDISM 62 0.0043
759 CHOLECYSTITIS 51 0.0043
760 UVEITIS 58 0.0043
761 COAGULOPATHY 71 0.0043
762 HAIR COLOUR CHANGES 53 0.0043
763 MUSCULOSKELETAL DISORDER 81 0.0043
764 BURNING SENSATION 298 0.0042
765 PULMONARY CONGESTION 56 0.0042
766 MUSCLE SPASMS 779 0.0042
767 LOWER RESPIRATORY TRACT INFECTION 193 0.0042
768 FAECES DISCOLOURED 92 0.0042
769 SPINAL FRACTURE 85 0.0042
770 BACK PAIN 982 0.0042
771 BLOOD CHOLESTEROL INCREASED 196 0.0042
772 PERICARDIAL EFFUSION 97 0.0042
773 JOINT STIFFNESS 110 0.0042
774 ACUTE HEPATIC FAILURE 57 0.0042
775 AMENORRHOEA 73 0.0042
776 PAIN 2554 0.0042
777 RASH MACULAR 145 0.0041
778 HEPATITIS 106 0.0041
779 INTESTINAL OBSTRUCTION 156 0.0041
780 INTENTIONAL PRODUCT MISUSE 362 0.0041
781 PRODUCT DISPENSING ERROR 90 0.0041
782 ABDOMINAL DISTENSION 428 0.0041
783 TOOTH DISORDER 91 0.0041
784 TRANSIENT ISCHAEMIC ATTACK 138 0.0041
785 PARAESTHESIA ORAL 59 0.0041
786 PLEURAL EFFUSION 248 0.0041
787 CHEST PAIN 754 0.0041
788 WHITE BLOOD CELL COUNT DECREASED 441 0.0041
789 DRUG EFFECT LESS THAN EXPECTED 60 0.0040
790 HAIR TEXTURE ABNORMAL 54 0.0040
791 PSORIASIS 527 0.0040
792 BLOOD TRIGLYCERIDES INCREASED 71 0.0040
793 INFUSION RELATED REACTION 266 0.0040
794 DRUG WITHDRAWAL SYNDROME 352 0.0040
795 POST PROCEDURAL COMPLICATION 77 0.0040
796 OEDEMA 217 0.0040
797 RASH MACULO-PAPULAR 89 0.0040
798 SKIN EXFOLIATION 337 0.0040
799 MUSCULOSKELETAL PAIN 209 0.0040
800 INFLUENZA LIKE ILLNESS 327 0.0040
801 EPISTAXIS 297 0.0040
802 LOCALISED INFECTION 96 0.0040
803 LIVER DISORDER 176 0.0040
804 BACTERIAL INFECTION 74 0.0040
805 NEUROPATHY PERIPHERAL 375 0.0039
806 CONJUNCTIVITIS 73 0.0039
807 PNEUMONITIS 107 0.0039
808 EJECTION FRACTION DECREASED 61 0.0039
809 SKIN REACTION 55 0.0039
810 RENAL IMPAIRMENT 327 0.0039
811 ORAL PAIN 87 0.0039
812 RASH 1693 0.0039
813 CELLULITIS 195 0.0039
814 SKIN ULCER 100 0.0039
815 GASTROINTESTINAL HAEMORRHAGE 323 0.0039
816 DIABETES MELLITUS 294 0.0039
817 SCAR 66 0.0039
818 SURGERY 226 0.0039
819 PARALYSIS 55 0.0038
820 INFECTION 555 0.0038
821 CEREBROVASCULAR ACCIDENT 647 0.0038
822 SWELLING 357 0.0038
823 LYMPHADENOPATHY 135 0.0038
824 THROAT TIGHTNESS 103 0.0038
825 ARTHROPATHY 211 0.0038
826 UNEVALUABLE EVENT 287 0.0038
827 CORONARY ARTERY OCCLUSION 52 0.0038
828 DRUG INEFFECTIVE 4979 0.0038
829 TYPE 2 DIABETES MELLITUS 127 0.0038
830 SYNOVITIS 68 0.0038
831 GASTROENTERITIS 55 0.0038
832 THROAT IRRITATION 169 0.0038
833 ABDOMINAL PAIN LOWER 95 0.0038
834 IMMUNODEFICIENCY 56 0.0038
835 ROAD TRAFFIC ACCIDENT 157 0.0037
836 MUCOSAL INFLAMMATION 98 0.0037
837 DISABILITY 74 0.0037
838 ACUTE MYOCARDIAL INFARCTION 110 0.0037
839 NEUTROPHIL COUNT DECREASED 152 0.0037
840 FLATULENCE 210 0.0037
841 THYROID DISORDER 57 0.0037
842 PLATELET COUNT DECREASED 394 0.0037
843 EYE SWELLING 137 0.0037
844 EYE DISORDER 121 0.0037
845 BONE DISORDER 67 0.0037
846 THROMBOCYTOPENIA 411 0.0037
847 GASTRIC DISORDER 126 0.0037
848 PANCREATITIS 194 0.0037
849 FLUID RETENTION 186 0.0037
850 THERAPEUTIC RESPONSE UNEXPECTED 164 0.0037
851 CONVULSION 209 0.0037
852 CARDIOMYOPATHY 54 0.0037
853 INFLAMMATION 188 0.0036
854 RHEUMATOID ARTHRITIS 413 0.0036
855 ANGINA PECTORIS 104 0.0036
856 HYPOACUSIS 156 0.0036
857 NEUTROPENIA 492 0.0036
858 FEBRILE NEUTROPENIA 239 0.0036
859 PULMONARY HYPERTENSION 75 0.0036
860 JOINT SWELLING 434 0.0036
861 HYPERGLYCAEMIA 131 0.0036
862 HEPATIC ENZYME INCREASED 243 0.0036
863 SNEEZING 79 0.0035
864 PULMONARY ARTERIAL HYPERTENSION 51 0.0035
865 SEPTIC SHOCK 153 0.0035
866 HEPATIC FAILURE 106 0.0035
867 CONTRAINDICATED PRODUCT ADMINISTERED 106 0.0035
868 CARDIAC FAILURE 281 0.0035
869 PERITONITIS 72 0.0035
870 CATARACT 207 0.0035
871 THERAPEUTIC RESPONSE DECREASED 210 0.0035
872 BASAL CELL CARCINOMA 54 0.0035
873 BLISTER 194 0.0035
874 BACK DISORDER 56 0.0034
875 LACRIMATION INCREASED 103 0.0034
876 DEAFNESS 89 0.0034
877 UNDERDOSE 248 0.0034
878 PRODUCT PRESCRIBING ISSUE 74 0.0034
879 HIP ARTHROPLASTY 52 0.0034
880 PROCEDURAL PAIN 94 0.0034
881 DERMATITIS 71 0.0034
882 LOWER LIMB FRACTURE 65 0.0034
883 FRACTURE 64 0.0034
884 PRODUCT USE COMPLAINT 53 0.0034
885 EMOTIONAL DISTRESS 407 0.0034
886 STOMATITIS 203 0.0033
887 BLOOD LACTATE DEHYDROGENASE INCREASED 53 0.0033
888 AGEUSIA 83 0.0033
889 HEPATOTOXICITY 74 0.0033
890 PRODUCT USE ISSUE 623 0.0033
891 ANAPHYLACTIC REACTION 183 0.0033
892 ALOPECIA 647 0.0033
893 BONE PAIN 192 0.0033
894 OSTEOMYELITIS 59 0.0033
895 HOSPITALISATION 500 0.0033
896 CARDIOVASCULAR DISORDER 82 0.0032
897 RENAL FAILURE ACUTE 137 0.0032
898 STAPHYLOCOCCAL INFECTION 106 0.0032
899 KNEE ARTHROPLASTY 67 0.0032
900 ACTIVITIES OF DAILY LIVING IMPAIRED 63 0.0032
901 LIVER FUNCTION TEST ABNORMAL 91 0.0031
902 DRY SKIN 412 0.0031
903 CEREBRAL INFARCTION 75 0.0031
904 ILL-DEFINED DISORDER 185 0.0030
905 ABORTION SPONTANEOUS 122 0.0030
906 EYE IRRITATION 175 0.0030
907 EYE PRURITUS 102 0.0030
908 RENAL DISORDER 141 0.0030
909 URTICARIA 500 0.0030
910 STEVENS-JOHNSON SYNDROME 66 0.0030
911 IMPAIRED HEALING 97 0.0030
912 CORONARY ARTERY DISEASE 89 0.0029
913 SKIN CANCER 63 0.0029
914 SKIN DISCOLOURATION 134 0.0029
915 DIABETES MELLITUS INADEQUATE CONTROL 51 0.0029
916 CHROMATURIA 65 0.0029
917 INTENTIONAL DRUG MISUSE 60 0.0029
918 DRUG EXPOSURE DURING PREGNANCY 97 0.0028
919 DRUG RESISTANCE 73 0.0028
920 PELVIC PAIN 51 0.0028
921 ERYTHEMA 573 0.0028
922 RASH PAPULAR 62 0.0028
923 CARDIAC DISORDER 258 0.0028
924 DRUG EFFECT INCOMPLETE 100 0.0028
925 FEMUR FRACTURE 85 0.0027
926 INTERSTITIAL LUNG DISEASE 132 0.0027
927 HAEMORRHAGE 283 0.0027
928 CYTOKINE RELEASE SYNDROME 54 0.0027
929 GLOSSODYNIA 60 0.0027
930 PLASMA CELL MYELOMA 104 0.0027
931 DIABETIC KETOACIDOSIS 64 0.0027
932 TOOTH LOSS 55 0.0027
933 INJECTION SITE REACTION 182 0.0026
934 ERUCTATION 51 0.0026
935 INJECTION SITE PRURITUS 176 0.0026
936 EXPOSURE VIA SKIN CONTACT 67 0.0026
937 PAIN OF SKIN 69 0.0026
938 LIP SWELLING 85 0.0025
939 CARDIAC FAILURE CONGESTIVE 205 0.0025
940 OCULAR HYPERAEMIA 121 0.0025
941 INJECTION SITE MASS 93 0.0025
942 PRURITUS GENERALISED 54 0.0025
943 DISEASE PROGRESSION 293 0.0025
944 VAGINAL HAEMORRHAGE 107 0.0025
945 LABORATORY TEST ABNORMAL 72 0.0024
946 HEPATIC FUNCTION ABNORMAL 90 0.0024
947 DEVICE MALFUNCTION 168 0.0024
948 ANAPHYLACTIC SHOCK 61 0.0024
949 NEOPLASM PROGRESSION 81 0.0023
950 EXTRA DOSE ADMINISTERED 92 0.0023
951 DEATH 1903 0.0022
952 INJECTION SITE SWELLING 169 0.0022
953 BLOOD GLUCOSE DECREASED 105 0.0022
954 INCORRECT DOSE ADMINISTERED 499 0.0022
955 GLYCOSYLATED HAEMOGLOBIN INCREASED 55 0.0022
956 VISUAL ACUITY REDUCED 72 0.0022
957 INJECTION SITE BRUISING 172 0.0022
958 ADVERSE EVENT 194 0.0021
959 NEEDLE ISSUE 61 0.0021
960 DEVICE ISSUE 187 0.0021
961 EXPIRED PRODUCT ADMINISTERED 69 0.0021
962 BONE DENSITY DECREASED 65 0.0021
963 MALIGNANT NEOPLASM PROGRESSION 209 0.0020
964 RASH GENERALISED 52 0.0020
965 DEVICE BREAKAGE 81 0.0020
966 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 404 0.0020
967 DRUG DEPENDENCE 319 0.0020
968 BLOOD GLUCOSE INCREASED 368 0.0020
969 MYOCARDIAL INFARCTION 337 0.0019
970 GYNAECOMASTIA 59 0.0019
971 INJURY 130 0.0018
972 INJECTION SITE PAIN 557 0.0018
973 DRUG DOSE OMISSION 300 0.0018
974 DRUG EFFECT DECREASED 97 0.0018
975 INJECTION SITE ERYTHEMA 221 0.0018
976 SKIN BURNING SENSATION 124 0.0017
977 PRODUCT QUALITY ISSUE 233 0.0017
978 ACNE 130 0.0017
979 DRUG ADMINISTRATION ERROR 51 0.0017
980 NEOPLASM MALIGNANT 109 0.0016
981 INJECTION SITE RASH 50 0.0016
982 SKIN IRRITATION 70 0.0015
983 ACCIDENTAL EXPOSURE TO PRODUCT 148 0.0014
984 DEVICE LEAKAGE 62 0.0014
985 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 100 0.0014
986 BREAST CANCER 131 0.0014
987 NO ADVERSE EVENT 217 0.0012
988 INJECTION SITE HAEMORRHAGE 84 0.0011
989 PROSTATE CANCER 70 0.0009
990 DEVICE EXPULSION 54 0.0008
991 DRUG DOSE OMISSION BY DEVICE 55 0.0007
992 PRODUCT STORAGE ERROR 52 0.0006